{
    "Trade/Device Name(s)": [
        "ImmunoCAP Thyroglobulin",
        "ImmunoCAP Thyroid Peroxidase",
        "ImmunoCAP Thyroglobulin IgG Antibodies Controls NLH",
        "ImmunoCAP Thyroid Peroxidase IgG Antibodies Controls NLH"
    ],
    "Submitter Information": "Phadia AB",
    "510(k) Number": "K072661",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "JNL",
        "JZO",
        "JJY"
    ],
    "Summary Letter Date": "November 20, 2007",
    "Summary Letter Received Date": "October 31, 2007",
    "Submission Date": "October 30, 2007",
    "Regulation Number(s)": [
        "21 CFR 866.5870"
    ],
    "Regulation Name(s)": [
        "Thyroid autoantibodies immunological system"
    ],
    "Analyte Class(es)": [
        "immunology",
        "autoimmune"
    ],
    "Analyte(s)": [
        "IgG antibodies to Thyroglobulin",
        "IgG antibodies to Thyroid Peroxidase"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ImmunoCAP 100",
        "ImmunoCAP 250"
    ],
    "Method(s)/Technology(ies)": [
        "Fluorescence Immunoassay"
    ],
    "Methodologies": [
        "Non-competitive solid phase EIA"
    ],
    "Submission Type(s)": [
        "Assay",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for ImmunoCAP Thyroglobulin and ImmunoCAP Thyroid Peroxidase assays and controls for detection and monitoring of IgG antibodies using ImmunoCAP platforms.",
    "Indications for Use Summary": "In vitro quantitative measurement of IgG antibodies specific for Thyroglobulin and Thyroid Peroxidase in human serum and plasma, as an aid in the diagnosis of certain thyroid diseases such as autoimmune thyroiditis and Graves' disease, for use in clinical and physician office laboratories.",
    "fda_folder": "Immunology"
}